Bank Of Montreal Catalent, Inc. Transaction History

Bank Of Montreal

  • $201 Billion
  • Q2 2025

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$56.16 - $60.96 $65.7 Million - $71.3 Million
1,169,044 Added 181.49%
1,813,167 $110 Million
Q2 2024

Aug 14, 2024
BUY
$53.58 - $57.02 $23.8 Million - $25.3 Million
444,084 Added 222.0%
644,123 $36.2 Million
Q1 2024

May 13, 2024
SELL
$42.56 - $59.82 $2.31 Million - $3.24 Million
-54,213 Reduced 21.32%
200,039 $11.3 Million
Q4 2023

Feb 08, 2024
BUY
$32.18 - $46.57 $1.14 Million - $1.66 Million
35,571 Added 16.27%
254,252 $11.4 Million
Q3 2023

Nov 01, 2023
SELL
$44.2 - $50.2 $1.68 Million - $1.9 Million
-37,903 Reduced 14.77%
218,681 $9.96 Million
Q2 2023

Aug 02, 2023
BUY
$31.86 - $67.26 $2.52 Million - $5.31 Million
78,947 Added 44.44%
256,584 $11.1 Million
Q1 2023

Jun 13, 2024
SELL
$45.44 - $74.26 $414,003 - $676,582
-9,111 Reduced 4.55%
190,928 $12.5 Million
Q4 2022

Feb 01, 2023
BUY
$41.39 - $81.0 $385,920 - $755,244
9,324 Added 5.54%
177,637 $7.99 Million
Q3 2022

Nov 10, 2022
SELL
$72.36 - $113.1 $2.86 Million - $4.47 Million
-39,520 Reduced 19.02%
168,313 $12.6 Million
Q2 2022

Aug 11, 2022
BUY
$87.2 - $114.05 $4.66 Million - $6.09 Million
53,417 Added 34.59%
207,833 $23.1 Million
Q1 2022

May 12, 2022
SELL
$94.19 - $124.49 $1.54 Million - $2.04 Million
-16,361 Reduced 9.58%
154,416 $17.1 Million
Q4 2021

Feb 11, 2022
SELL
$119.57 - $139.07 $34.7 Million - $40.4 Million
-290,194 Reduced 62.95%
170,777 $22 Million
Q3 2021

Nov 12, 2021
SELL
$109.17 - $142.35 $2.66 Million - $3.47 Million
-24,375 Reduced 5.02%
460,971 $62.1 Million
Q2 2021

Aug 12, 2021
BUY
$100.34 - $115.69 $48.7 Million - $56.1 Million
485,346 New
485,346 $53.4 Million

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email